Revive Therapeutics Ltd.
OTC: RVVTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Michael Frank
- Employees
- 3
- Headquarters
- Toronto, Canada
- IPO year
- 2015
- Market cap
- $8.0M
- Website
- https://www.revivethera.com
Loading RVVTF…
Loading profile data…Frequently asked questions about RVVTF
What does Revive Therapeutics Ltd. (RVVTF) do?
Revive Therapeutics Ltd., a life sciences firm founded in 2012 and headquartered in Toronto, Canada, is focused on discovering and advancing treatments for uncommon diseases and infectious illnesses. The company maintains a pharmaceutical pipeline centered on cannabinoids, specifically targeting rare inflammatory conditions. Key developments in...
Where does RVVTF trade?
Revive Therapeutics Ltd. (RVVTF) trades on the Other OTC.
What sector is RVVTF in?
Revive Therapeutics Ltd. (RVVTF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Revive Therapeutics Ltd.?
Michael Frank is the chief executive officer of Revive Therapeutics Ltd. (RVVTF).
Where is Revive Therapeutics Ltd. headquartered?
Revive Therapeutics Ltd. is headquartered in Canada.
Does RVVTF pay a dividend?
Revive Therapeutics Ltd. (RVVTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RVVTF go public?
Revive Therapeutics Ltd. (RVVTF) completed its initial public offering in 2015.